TITLE
Recommendation to authorize City Manager, or designee, to execute an agreement, and any subsequent amendments, with Wellpartner, LLC, to serve as Administrator of a 340B Pharmacy Program on behalf of the Health and Human Services Department, a covered entity, providing reduced pricing for eligible prescription drugs, for the period of October 1, 2018 through September 30, 2020;
Authorize City Manager, or designee, to execute an agreement, and any subsequent amendments, with Bella Vida Pharmacy, Inc., to serve as the Contract Pharmacy, to dispense eligible drugs to qualifying patients under the 340B Pharmacy Program, for the period of October 1, 2018 through September 30, 2020; and
Increase appropriations in the Health Fund (SR 130) in the Health and Human Services Department (HE) by $213,000, offset by revenue. (Citywide)
DISCUSSION
In 1992, Congress enacted Section 340B of the Public Health Service Act. Section 340B requires pharmaceutical manufacturers to enter into an agreement, called a Pharmaceutical Pricing Agreement (PPA), with the Secretary of Health and Human Services. Under the PPA, the manufacturer agrees to provide front-end discounts on covered outpatient drugs purchased by specified providers, called "covered entities," that serve the nation's most vulnerable patient populations. The purpose of the 340B Program is to enable covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.
The intent of the 340B Program is to strengthen covered entities so they may provide efficient and effective service to their clients. Through the 340B Pharmacy Program, the Health and Human Services Department (Health Department), as a qualifying covered entity, is eligible to purchase outpatient prescription drugs at preferential, reduced prices from certain drug manufacturers and/or drug wholesalers. Under the terms of the recommended agreements, Bella Vida will a...
Click here for full text